DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Siegel AB, Cohen EI, Ocean A , et al.
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.
J Clin Oncol 2008;
26 (18) 2992-2998
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.